Search

I converted to the extended deep plane facelift and neck lift with a shorter skin flap elevation in the face to achieve a more complete release of the facial ligaments to obtain more mobilization of the skin/superficial musculoaponeurotic system composite flap, and a more medial suspension resulting in improved correction of the midface, nasolabial fold, marionette fold and jowl. Treatment of the deep neck structures allowed for more refinement of the submentum in the deep neck lift procedures as well. In this article, we shall review the surgical technique of the deep plane facelift and neck lift as well as postoperative management pearls, the management of complications from the procedure, and the incorporation of ancillary procedures., Competing Interests: R.K.B. is also a consultant for Allergan Aesthetics., (Thieme. All rights reserved.)

Background: Delayed-onset adverse reactions to hyaluronic acid (HA) fillers are uncommon but have received increased attention, particularly with regard to late-onset nodules. Globally, there is a need for comprehensive prevention and management strategies., Methods: Experts with clinical practices in diverse regions of the world and extensive experience in managing complications related to HA fillers convened to propose and evaluate approaches to prevent delayed-onset adverse reactions after HA filler administration and manage late-onset nodules., Results: The expert panel agreed to define delayed-onset adverse reactions as those presenting more than 4 weeks posttreatment, with swelling, induration, and nodulation being the most common clinical signs. The panel recommended 5 general key approaches for the prevention of delayed-onset reactions (patient selection, anatomic location of injection/product selection, aseptic technique, injection procedure/filler, and posttreatment care). Strategies recommended for managing late-onset nodules included oral antibiotics, oral steroids, nonsteroidal anti-inflammatory drugs if needed, hyaluronidase for noninflammatory nodules (recognizing the limitations and regional availability of this treatment), intralesional antibiotics, intralesional immunosuppressive drugs such as steroids and fluorouracil, and surgical excision as a last resort. The panel noted that late-onset nodules may vary in both clinical presentation and etiology, making them challenging to address or prevent, and stressed individualized treatment based on clinical presentation. Regional differences in aseptic protocols, antibiotic selection, and steroid formulations were described., Conclusion: Insights from global experts on approaches to prevent and manage delayed-onset adverse reactions following HA filler administration, including late-onset nodules, support clinicians worldwide in optimizing patient outcomes and safety., Competing Interests: Disclosure: Writing and editorial assistance with manuscript preparation was provided to the authors by Regina Kelly, MA, of Peloton Advantage, LLC, an OPEN Health company, Parsippany, N.J., and was sponsored by Allergan plc, Dublin, Ireland. No honoraria or other forms of payment were made for authorship. Dr Batniji is a consultant, speaker, and advisory board member for Allergan plc. Dr Goodman is an advisory board member, clinical investigator, and consultant for Allergan plc; and is a speaker, advisory board member, and consultant for Galderma. Dr Jones is an investigator, consultant, and advisory board member for Allergan plc; and an investigator for Galderma. Dr Philipp-Dormston is an investigator, consultant, speaker, and advisory board member for Allergan plc and Galderma. Dr Heydenrych is an advisory board member and consultant for Allergan plc. Dr Delorenzi is an advisory board member and consultant for Allergan plc; and is a medical director for Allergan Canada and Merz Canada (complications management). Dr Trindade De Almeida is a speaker, advisory board member, and investigator for Allergan plc and Merz. Dr De Boulle is an advisory board member and consultant for Allergan plc and Laboratoires Genevrier. A. Swift is an advisory board member, speaker, and investigator for Allergan plc, Merz, and Galderma., (Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.)

Competing Interests: Disclosure The authors report no conflicts of interest in this work.

Neck lift surgery performed in isolation or in conjunction with a facelift provides a more youthful cervicomental angle. Complications related to neck lift surgery vary from contour irregularities that may improve with time or conservative measures,to contour irregularities that persist and may benefit from delayed surgical intervention, to expanding hematomas that require immediate surgical intervention. This article reviews complications of neck lift surgery and their etiologies, methods to minimize the incidence of these complications, and management.

The non-Caucasian face has many unique attributes, including skin tone, texture, elasticity, skin thickness, and subcutaneous fat content. These differences may place the patient at increased risk for scarring and pigmentation issues. In this paper, the authors discuss treatment options, surgical and nonsurgical, for rejuvenation of the upper face and midface, including the periorbital region. The selection of the proper treatment must be coupled with a thorough understanding of the age-related changes that occur in the non-Caucasian face to meet and hopefully exceed the patient's expectations., (Copyright 2010 Elsevier Inc. All rights reserved.)

We report a case of unilateral tonsillar lymphoepithelioma with extension into the ipsilateral parapharyngeal space, and we review the clinical, histologic, and radiographic findings of the case. The patient presented with a tonsillar mass that was confirmed on biopsy to be lymphoepithelioma. Computed tomography demonstrated ipsilateral parapharyngeal space involvement. Association with Epstein-Barr virus was not assessed since it does not affect the treatment modality. We also review the literature and discuss the diagnosis and current treatment options.

Blepharoplasty is one of the most common cosmetic surgeries performed on the male patient. Whereas in the past the male patient would present later in life for eyelid surgery to address functional issues, he now presents earlier in life with an interest in aesthetic improvement as the primary motivating factor. This article reviews the approach of the senior author (SWP) to rejuvenation of the lower eyelid complex. Specifically, we discuss the indications for and techniques of the transcutaneous and transconjunctival approaches for blepharoplasty. As well, adjunctive procedures for rejuvenation of the lower eyelid complex, including fat transposition, lateral canthoplasty, and skin resurfacing, are reviewed.

Hemangiomas are the most common tumor of infancy and childhood, affecting approximately 10% of infants by the age of 1 year. The diagnosis can nearly always be made by the patient's history and findings on physical examination. Prior to the classification system outlined by Mulliken and Glowacki, the natural course of hemangiomas was poorly understood and treatment was inconsistent, ranging from benign neglect to deforming surgical intervention. However, with an improved understanding of the natural course of hemangiomas, as well as advances in anesthesia, laser technology, medical therapy, and surgical methods, an aesthetic approach to facial hemangiomas was developed by the senior author (E.F.W.) and is reviewed in this article.

Many techniques have been developed for rejuvenation of the midface. This article describes the technique of subperiosteal midface elevation via an endoscopic brow incision approach developed by the senior author and reviews the results of this technique, with specific emphasis upon the effect on lower facial rejuvenation.

Purpose of Review: The purpose of this review is to discuss current trends in the medicinal use of botulinum toxin in head and neck and facial plastic surgery. The basic science of botulinum toxin is presented along with a comparison of the subtypes currently available on the market. Site-specific applications of botulinum toxin in the head and neck region are presented., Recent Findings: The use of botulinum toxin continues to expand, both in volume and in number of applications. The main application of botulinum toxin in facial plastic surgery is in the effacement of dynamic or hyperkinetic facial lines. The granting of US Food and Drug Administration approval for the use of Botulinum Toxin type A in the treatment of glabella lines marks a major milestone for the more widespread usage of this product in cosmetic settings. Additional cosmetic applications include crow's feet, marionette lines, and platysma banding. Noncosmetic applications in the head and neck include dystonias (including torticollis), facial and generalized muscle spasms, migraine headaches, hyperhidrosis, spasmodic dysphonia, sialorrhea, gustatory sweating, and involuntary movement disorders., Summary: The use of botulinum toxin in the treatment of hyperkinetic conditions and disorders of excessive salivation is well established and enjoys an excellent safety profile. The cosmetic use of botulinum toxin continues to expand. The chronic use of botulinum toxin specifically for cosmetic purposes is worthy of additional study.

Background: Expanded polytetrafluoroethylene (ePTFE) and silicone are safe and relatively biocompatible materials., Objective: To compare, using multiple histologic parameters, the tissue response to a standard silicone soft tissue implant with the response to a modified ePTFE implant. The modified form of ePTFE is reinforced with fluorinated ethylene propylene (FEPRePTFE), which provides increased pliability and material integrity., Methods: The implants were placed into a subperiosteal pocket over the skull of adult New Zealand white rabbits. At 7, 30, and 90 days after implantation, en bloc tissue specimens, including skin, implants, surrounding soft tissue, and underlying bone were harvested for gross and histologic evaluation., Outcome Measures: The tissue response to the implants was assessed with respect to the number of foreign body giant cells present, the thickness of the fibrous capsule, and the general inflammatory response (n = 6 for each implant at each evaluation period)., Results: There were no cases of rejection, extrusion, or infection. The silicone implants elicited a significantly thicker capsule and less neovascularization (P<.05)., Conclusion: The FEPRePTFE demonstrated a favorable tissue response when compared with silicone, particularly in regard to capsule thickness and vascular ingrowth.